Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica

被引:16
|
作者
Wang, Honghao [1 ,2 ]
Wang, Conghui [3 ]
Qiu, Wei [2 ]
Lu, Zhengqi [2 ]
Hu, Xueqiang [2 ]
Wang, Kai [2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Multiple Sclerosis Ctr, Guangzhou 510275, Guangdong, Peoples R China
[3] Anhui Med Univ, Affiliated Hosp 1, Dept Geriatr, Hefei, Anhui, Peoples R China
关键词
Neurofilament light subunit; Neurofilament heavy subunit; Neuromyelitis optica; Multiple sclerosis; FIBRILLARY ACIDIC PROTEIN; MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; CSF NEUROFILAMENT; AXONAL INJURY; BIOMARKERS; MARKER; PHOSPHORYLATION; DAMAGE;
D O I
10.1016/j.neuint.2013.10.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Axonal injury is the correlate of disease progression in NMO and MS. Neurofilament (NI) belongs to neuron specific intermediate filaments located in axons. Nf protein subunits are potential biomarkers in cerebrospinal fluid (CSF) for acute axonal injury. However, whether CSF NfH and Nil levels are elevated in NMO patients has remained unclear. Methods: Nf light subunit (NE) and Nf heavy subunit NfH in cerebrospinal fluid were measured by enzyme-linked immunosorbent assay (ELISA) in NMO (n = 32), MS (n = 25), and other non-inflammatory neurological disease patients (OND, n = 18). Results: CSF pNf-H levels were increased in the NMO patients compared with OND patients (p = 0.001). CSF NfL levels in the NMO patients were also higher compared with MS patients (p 0.001), and OND patients (p = 0.000001). When comparing NfL levels between MS and OND patients, there also significant differences (p = 0.0003). NMO and MS patients revealed a trend to an increased disability with increased CSF NfL during relapse (NMO: p = 0.006; MS: p = 0.017). There is positive relationship between CSF pNf-H and disability of MS patients (p = 0.041). Conclusions: CSF levels of NfL are increased in NMO patients and reflect the disease severity in NMO. (C) 2013 Published by Elsevier Ltd.
引用
收藏
页码:805 / 808
页数:4
相关论文
共 50 条
  • [31] Neuromyelitis Optica
    Patterson, Sarah L.
    Goglin, Sarah E.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2017, 43 (04) : 579 - +
  • [32] Cerebrospinal fluid interleukin-6 may be a biomarker for conversion of clinically isolated syndrome to neuromyelitis optica spectrum disorder
    Wei, Yuzhen
    Wang, Huabing
    Tian, Decai
    Song, Tian
    Sun, Jiali
    Lu, Ping
    Zhang, Lulin
    Zhang, Xinghu
    Yin, Linlin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 95
  • [33] Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis
    Fialova, Lenka
    Bartos, Ales
    Svarcova, Jana
    Zimova, Denisa
    Kotoucova, Jolana
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 259 (1-2) : 81 - 87
  • [34] Decreased kynurenine in cerebrospinal fluid and potential role in neuromyelitis optica spectrum disorder
    Peng, Fuhua
    She, Hongda
    Wang, Yuge
    Xu, Li
    Shan, Yilong
    Chang, Yanyu
    Zhong, Xiaonan
    Li, Rui
    Qiu, Wei
    Shu, Yaqing
    Tan, Sha
    JOURNAL OF NEUROCHEMISTRY, 2023, 165 (02) : 259 - 267
  • [35] Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis
    Fialova, Lenka
    Bartos, Ales
    Svarcova, Jana
    Zimova, Denisa
    Kotoucova, Jolana
    Malbohan, Ivan
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 262 (1-2) : 113 - 120
  • [36] Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
    Sato, Douglas Kazutoshi
    Callegaro, Dagoberto
    de Haidar Jorge, Frederico M.
    Nakashima, Ichiro
    Nishiyama, Shuhei
    Takahashi, Toshiyuki
    Simm, Renata Faria
    Apostolos-Pereira, Samira Luisa
    Misu, Tatsuro
    Steinman, Lawrence
    Aoki, Masashi
    Fujihara, Kazuo
    ANNALS OF NEUROLOGY, 2014, 76 (02) : 305 - 309
  • [37] Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker
    Misu, T.
    Takano, R.
    Fujihara, K.
    Takahashi, T.
    Sato, S.
    Itoyama, Y.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (05) : 575 - 577
  • [38] Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations
    Bergamaschi, R
    Tonietti, S
    Franciotta, D
    Candeloro, E
    Tavazzi, E
    Piccolo, G
    Romani, A
    MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (01) : 2 - 4
  • [39] Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis
    Wang, Honghao
    Wang, Kai
    Wang, Conghui
    Xu, Fangcheng
    Zhong, Xiaonan
    Qiu, Wei
    Hu, Xueqiang
    NEUROIMMUNOMODULATION, 2013, 20 (02) : 113 - 118
  • [40] Biomarkers for neuromyelitis optica
    Chang, Kuo-Hsuan
    Ro, Long-Sun
    Lyu, Rong-Kuo
    Chen, Chiung-Mei
    CLINICA CHIMICA ACTA, 2015, 440 : 64 - 71